United States· US:71335-2532_334cb4f5-b33c-4871-9777-7bd9d0f4cab0
Isosorbide Mononitrate
A isosorbide mononitrate product containing isosorbide mononitrate, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Isosorbide mononitrate is registered in 13 of 19 countries.
Countries holding a registration under ATC C01DA14 (isosorbide mononitrate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Isosorbide mononitrate · ATC C01DA14
13 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isosorbide mononitrate costs, country by country.
Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.078 in United States to $0.15 in Italy — a ×1.9 gap.
- United States: $0.078 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Isosorbide mononitrate · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- IT Italy$0.15
- US United States$0.078 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ISOSORBIDE MONONITRATE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- C01DA14
- ATC class
- Isosorbide mononitrate
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc117133525321100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-1)
- ndc11713352532230 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-2)
- ndc11713352532360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-3)
- ndc11713352532490 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-4)
- ndc11713352532510 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2532-5)
- ndc1171335-2532-5
- ndc1171335-2532-1
- ndc1171335-2532-2
- ndc1171335-2532-3
- ndc1171335-2532-4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
275 interactions on record for isosorbide mononitrate.
Graded by severity as the source publishes them — 71 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isosorbide mononitrate · interactions on record
275 records
- 71 moderate
- 1 minor
- 198 info
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isosorbide mononitrate in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarmil XL 60mg tabletsMilpharm Ltd
- NorwayImdurTopRidge Pharma (Ireland) Limited
- CanadaAPO-ISMNAPOTEX INC
- IrelandImdur 60 mg Prolonged-release Film-coated TabletsTopridge Pharma (Ireland) Limited
- ItalyISOSORBIDE MONONITRATOSANDOZ S.P.A.
- IcelandFem-Mono RetardViatris Limited
- FinlandFem-Mono RetardGenerics (UK) Limited
- SwedenImdur 60 mg DepottablettTopRidge Pharma (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ismn Genericon, Monoket Retard
- Bulgaria · Oликард, Изосорб
- Cyprus · Imdur, Monorem
- Czechia · Mono Mack Depot, Monosan
- Germany · Elantan Long, Is 5 Mono
- Denmark · Farmidur, Fem-Mono Retard
- Estonia · Imdur, Isomonit
- Spain · Coronur, Coronur Retard
- Finland · Imdur, Isangina
- United Kingdom (Northern Ireland) · Angitate, Carmil Xl
- Greece · Dilavase, G-Dil
- Croatia · Ismn Genericon, Isocard
- Hungary · Mono Mack Depot, Olicard
- Ireland · Elantan, Elantan La
- Iceland · Fem-Mono Retard, Imdur
- Italy · Duronitrin, Elan
- Lithuania · Imdur, Ismn Stada
- Latvia · Imdur, Ismn Stada
- Malta · Imdur, Monorem R
- Netherlands · Isosorbide Mononitraat Retard Rph, Isosorbide Mononitraat Retard Viatris
- Norway · Imdur, Isomex
- Poland · Effox Long, Mononit
- Portugal · Imdur, Ismo
- Romania · Mononitron Ep, Olicard Retard
- Sweden · Imdur, Ismo
- Slovenia · Monosan, Olicard
- Slovakia · Mono Mack Depot, Monosan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/acfdb7e0-6eb8-4eda-a950-0f005f6c3370 GET /v1/drugs/acfdb7e0-6eb8-4eda-a950-0f005f6c3370?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "ISOSORBIDE MONONITRATE",
"productndc": "71335-2532",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA075522",
"marketing_category": "ANDA"
}See everything about isosorbide mononitrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.